Literature DB >> 19381761

Use of tranexamic acid for disseminated intravascular coagulation with excessive fibrinolysis associated with aortic dissection in a patient with chronic renal failure.

Shun-Ichi Kimura1, Jun Odawara1, Takatoshi Aoki1, Masayuki Yamakura1, Masami Takeuchi1, Yoshihiko Watanabe2, Kosei Matsue3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19381761     DOI： 10.1007/s12185-009-0309-2

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  18 in total

Review 1.  Disseminated intravascular coagulation.

Authors:  M Levi; H Ten Cate
Journal:  N Engl J Med       Date:  1999-08-19       Impact factor: 91.245

Review 2.  Hemostatic drugs.

Authors:  P M Mannucci
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

Review 3.  Clinical pharmacology of aminocaproic and tranexamic acids.

Authors:  I M Nilsson
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1980

4.  Effect of combined therapy of danaparoid sodium and tranexamic acid on chronic disseminated intravascular coagulation associated with abdominal aortic aneurysm.

Authors:  Yasuo Ontachi; Hidesaku Asakura; Masahisa Arahata; Yasuko Kadohira; Mio Maekawa; Tomoe Hayashi; Masahide Yamazaki; Eriko Morishita; Masanori Saito; Shinji Minami; Shinji Nakao
Journal:  Circ J       Date:  2005-09       Impact factor: 2.993

5.  Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients.

Authors:  F Rodeghiero; G Avvisati; G Castaman; T Barbui; F Mandelli
Journal:  Blood       Date:  1990-06-01       Impact factor: 22.113

6.  Tranexamic acid for control of haemorrhage in acute promyelocytic leukaemia.

Authors:  G Avvisati; J W ten Cate; H R Büller; F Mandelli
Journal:  Lancet       Date:  1989-07-15       Impact factor: 79.321

7.  Fatal thromboembolism in acute promyelocytic leukemia during all-trans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage.

Authors:  S Hashimoto; T Koike; W Tatewaki; Y Seki; N Sato; T Azegami; N Tsukada; H Takahashi; H Kimura; M Ueno
Journal:  Leukemia       Date:  1994-07       Impact factor: 11.528

8.  Aortic aneurysms and consumptive coagulopathy.

Authors:  P D Micallef-Eynaud; C A Ludlam
Journal:  Blood Coagul Fibrinolysis       Date:  1991-06       Impact factor: 1.276

9.  Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group.

Authors:  Miguel A Sanz; Guillermo Martín; Marcos González; Angel León; Chelo Rayón; Concha Rivas; Dolors Colomer; Elena Amutio; Francisco J Capote; Gustavo A Milone; Javier De La Serna; José Román; Eva Barragán; Juan Bergua; Lourdes Escoda; Ricardo Parody; Silvia Negri; María J Calasanz; Pascual Bolufer
Journal:  Blood       Date:  2003-10-23       Impact factor: 22.113

10.  Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio.

Authors:  K Kario; T Matsuo; K Kodama; M Matsuo; K Yamamoto; H Kobayashi
Journal:  Haemostasis       Date:  1992
View more
  2 in total

1.  Tranexamic Acid Controlled Chronic Disseminated Intravascular Coagulation Associated with Aortic Dissection and Patent False Lumen for Three Years.

Authors:  Yodo Gatate; Nobuyuki Masaki; Atsushi Sato; Risako Yasuda; Takayuki Namba; Hirotaka Yada; Akio Kawamura; Takeshi Adachi
Journal:  Intern Med       Date:  2017-04-15       Impact factor: 1.271

2.  Successful Treatment with Edoxaban for Disseminated Intravascular Coagulation in a Case of Aortic Dissection Complicated with Immune Thrombocytopenic Purpura.

Authors:  Shun Uemura; Hironori Kobayashi; Yoshinobu Seki; Yuki Okoshi; Hirohito Sone; Nobuhiko Nomoto
Journal:  Intern Med       Date:  2020-05-08       Impact factor: 1.271
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.